Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of MenACYW Conjugate Vaccine in Toddlers
NCT03205371Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2016
- Primary completion
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of Meningococcal ACWY conjugate vaccine in invasive meningococcal disease (IMD), sponsored by Sanofi. Started Nov 2016; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT03205371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205371.